Glanbia Plc ADR (OTC:GLAPY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday.

According to Zacks, “Glanbia Plc engages in the manufacture and distribution of dairy and nutritional food products. Its operating segments include Glanbia Performance Nutrition, Global Ingredients, Dairy Ireland and Joint Ventures and Associates. Glanbia Performance Nutrition segment comprises of performance nutrition products under the Optimum Nutrition, BSN, Isopure, Nutramino and ABB brands. Global Ingredients segment includes American-style cheddar cheese, micro-nutrient premixes and dairy and non-dairy nutritional solutions. Dairy Ireland segment consists of consumer products and agribusiness. Joint Ventures and Associates segment covers Glanbia Ingredients Ireland, Glanbia Cheese and Southwest Cheese. Glanbia Plc is headquartered in Kilkenny, Ireland. “

Glanbia Plc ADR (OTC:GLAPY) traded up 0.26% during midday trading on Tuesday, hitting $94.70. The stock had a trading volume of 176 shares. The company’s 50 day moving average price is $97.00 and its 200-day moving average price is $99.29. Glanbia Plc ADR has a 52-week low of $80.15 and a 52-week high of $101.75. The stock has a market cap of $5.59 billion and a PE ratio of 21.50.

ILLEGAL ACTIVITY WARNING: This report was first reported by American Banking News and is the sole property of of American Banking News. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at

About Glanbia Plc ADR

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company’s Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages.

Get a free copy of the Zacks research report on Glanbia Plc ADR (GLAPY)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Glanbia Plc ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia Plc ADR and related companies with's FREE daily email newsletter.